ArticleOncoTargets and therapy2015

High expression of UBD correlates with epirubicin resistance and indicates poor prognosis in triple-negative breast cancer.

Tao Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.